BitcoinWorld

Price Analysis: Injective (INJ) Rises More Than 3% In 24 Hours
Latest News News

Price Analysis: Injective (INJ) Rises More Than 3% In 24 Hours

Over the past 24 hours, the price of Injective (INJ) has risen 3.86% to $39.85. 

INJ Price Chart | Source: Coinstats

 

This is contrary to it’s negative trend over the past week where Injective (INJ) has experienced a 6.0% loss, moving from $41.94 to its current price. As it stands right now, the coin’s all-time high is $45.01.

The chart below compares the price movement and volatility for Injective over the past 24 hours (left) to its price movement over the past week (right). 

INJ Price And Volatility

 

The gray bands are Bollinger Bands, measuring the volatility for both the daily and weekly price movements. 

See Also: Dormant Ethereum (ETH) Wallet Wakes Up After Over 8 Years

The wider the bands are, or the larger the gray area is at any given moment, the larger the volatility.

The trading volume for the coin has tumbled 53.0% over the past week while the circulating supply of the coin has risen 0.22%. 

INJ Circulating Supply And Trading Volume

 

This brings the circulating supply to 84.73 million. According to our data, the current market cap ranking for INJ is #29 at $3.38 billion.

Disclaimer: The information provided is not trading advice. Bitcoinworld.co.in holds no liability for any investments made based on the information provided on this page. We strongly recommend independent research and/or consultation with a qualified professional before making any investment decisions.

Crypto products and NFTs are unregulated and can be highly risky. There may be no regulatory recourse for any loss from such transactions. Crypto is not a legal tender and is subject to market risks. Readers are advised to seek expert advice and read offer document(s) along with related important literature on the subject carefully before making any kind of investment whatsoever. Crypto market predictions are speculative and any investment made shall be at the sole cost and risk of the readers.